海外の感染症の最新の流行状況を情報をお知らせいたします。
※出典が海外のため原文のまま掲載しています。最新の記事はこちら

2023年12月15日時点の情報

Nigeria to vaccinate 7.7 million girls against leading cause of cervical cancer|24 October 2023|African Region
Abuja, 24 October 2023 – Nigeria today introduced the human papillomavirus (HPV) vaccine into its routine immunization system, aiming to reach 7.7 million girls – the largest number in a single round of HPV vaccination in the African region – in a vaccination drive against the virus that causes nearly all cases of cervical cancer. Girls aged 9–14 years will receive a single dose of the vaccine, which is highly efficacious in preventing infection with HPV types 16 and 18 that are known to cause at least 70% of cervical cancers.

Transitioning from BU-LABNET to Skin NTD LABNET|06 November 2023|African Region
The network of Buruli ulcer PCR laboratories (BU-LABNET) in the WHO African Region concluded its fifth annual meeting held at the esteemed Noguchi Memorial Institute for Medical Research in Accra, Ghana on 23–25 October 2023.

First WHO tri-regional health leadership training gets underway |30 October 2023|African Region
Brazzaville/Istanbul – In a first of its kind, the World Health Organization (WHO) Regional Office for Africa’s Pathways to Leadership for Health Transformation Programme this week gathered experts from three of the Organization’s regional offices to equip them with crucial skills on health leadership to help bolster individual and organizational efforts towards a stronger future for global health.

Eritrea empowered the health workers on Essential care during Labor and Birth (ECL&B…|14 October 2023|African Region
Eritrea is one of the first countries in the WHO/AFRO region that conducted the Training of Trainers (TOT) on coaching and mentoring on Essential care during Labour and Birth (ECL&B), Early Essential Newborn Care, and Safer use of oxygen during October 9-14, 2023.

Senegal, WHO launch regional emergency hub to bolster Africa’s response to health cr…|14 December 2023|African Region
Dakar – The Government of Senegal and World Health Organization (WHO) today inaugurated a regional health emergency hub in the Senegalese capital Dakar to further bolster the African region’s capacity to respond swiftly and effectively to health crises and save lives.

Five African countries report anthrax outbreaks, over 1100 cases recorded|11 December 2023|African Region
Brazzaville – Five countries in East and southern Africa are experiencing anthrax outbreaks, with more than 1100 suspected cases and 20 related deaths reported since the start of the year. A total of 1166 suspected and 37 confirmed cases have been recorded in Kenya, Malawi, Uganda, Zambia and Zimbabwe – where the disease is endemic, with seasonal outbreaks every year – according to data reported to World Health Organization (WHO).

Scaling up country support for NTD eradication|06 December 2023|African Region
In 2021, the World Health Organization (WHO) unveiled the neglected tropical diseases (NTD) roadmap 2021-2030, initiating a decade dedicated on controlling, eliminating, and eradicating NTDs. The WHO Regional Office for Africa is stepping up support for countries on the implementation of the roadmap to bolster the fight against NTDs and accelerate progress towards attainment of the roadmap targets and goals.

WHO Africa welcomes new commitment by global partners to end neglected tropical dise…|06 December 2023|African Region
Brazzaville – The fight against neglected tropical diseases (NTDs) has received a major boost with a landmark commitment by donors and partners to invest over US$ 777 million boost efforts to eliminate and eradicate NTDs.

WHO, partners urge stronger action to accelerate childhood vaccination in Africa|30 November 2023|African Region
Lusaka – With one in five children in Africa still missing basic, life-saving vaccines, World Health Organization (WHO) and partners are calling for accelerated action to reach all children and put the continent back on track to achieve the Immunization Agenda 2030 goals towards reducing illness and deaths due to vaccine-preventable diseases.

Anthrax|8 December 2023|Zambia
In June 2023, human and animal cases were reported in the Kanchindu and Siameja veterinary camps of Sinazongwe district. Twenty-six human cases developed sores on their face, arms, and fingers after consuming meat from three wild hippopotamus carcasses. The first human case was reported on 16 June 2023 and laboratory confirmed by culture at the Lusaka CVRI. On the animal side, 13 domestic animals including cattle (10) and goats (3) out of Sinazongwe district susceptible population of 65 000 (30 000 cattle and 35 000 goats), under free range extensive traditional management, died of suspected anthrax. Cattle and goat specimens tested by culture at the Lusaka CVRI returned positive for anthrax on 17 July 2023. Until 1 November, anthrax outbreaks affecting animals and humans were reported in other Southern, Northwestern, and Western provinces.

Influenza A(H1N2) variant virus infection|1 December 2023|United Kingdom of Great Britain and Northern Ireland
Further laboratory analyses conducted at the Worldwide Influenza Centre at the Francis Crick Institute (a WHO Collaborating Centre) and the World Organization for Animal Health (WOAH) avian and swine influenza reference laboratory at the Animal and Plant Health Agency, indicated that this influenza A(H1N2)v virus belongs to the swine influenza virus genetic clade 1B.1.1. Similar A(H1N2) viruses from this genetic clade have been previously detected in pigs in the United Kingdom. However, this is the first time a virus from this swine genetic clade has been detected in a human in the United Kingdom.

Avian Influenza A (H5N1)|29 November 2023|Cambodia
The first reported case developed fever, cough and shortness of breath on 19 November 2023, was treated at home for several days, and then visited a hospital on 23 November. At the hospital, samples were collected and transported to the National Institute of Public Health for testing and was subsequently confirmed as influenza A(H5N1) by RT-qPCR assays at the National Laboratory at National Institute of Public Health and reconfirmed by Institute Pasteur du Cambodge. The case was admitted and in intensive care at the hospital and passed away on 26 November 2023. The second reported case was detected during active surveillance in response to the first reported case, for additional cases with clinical presentation including fever, cough and rash. The case was transported to hospital on 25 November 2023 for testing with samples returning positive for influenza A(H5N1) by RT-qPCR assays at the National Laboratory at National Institute of Public Health and reconfirmed by at the Institute Pasteur du Cambodge. The case is currently admitted in an isolation room in the respiratory ward of the hospital and undergoing treatment. Epidemiological investigation shows both cases had exposure to backyard birds which were reported to be sick and dead, over the past month. No epidemiological linkage of these cases has yet been confirmed other than that they both resided in the same village.

Risk Assessment for public health related to Dengue in the Americas Region – 12 December 2023|12 Dec 2023|Pan American Health Organization
Risk Assessment for public health related to Dengue in the Americas Region – 12 December 2023

Epidemiological Alert – Sustained circulation of dengue in the Region of the Americas – 5 December 2023|5 Dec 2023|Pan American Health Organization
In light of the beginning of the peak dengue circulation season in the southern hemisphere, the persistence of viral activity in the Central American Isthmus subregion and Mexico, and the identification of serotypes, mainly DENV-3, that had not circulated for several years in some areas, the Pan American Health Organization / World Health Organization (PAHO/WHO) encourages Member States to continue efforts to maintain surveillance, early diagnosis, and timely treatment of dengue cases and other arboviruses. This is aimed at preventing complications and deaths associated with these diseases. At the same time, it calls for the intensification of preparedness actions within healthcare services to facilitate access and proper management of patients.

Epidemiological alert: Invasive disease caused by group A streptococci – 28 November 2023|28 Nov 2023|Pan American Health Organization
In December of 2022, the World Health Organization (WHO) released an alert on the increase in cases of invasive group A streptococcal (iGAS) infection in Europe, especially in children under 10 years of age. During the same period, the Pan-American Health Organization (PAHO) issued an information note following cases of invasive GAS disease reported by Uruguay. In November of 2023, Argentina reported a significant increase in the notification of cases and deaths from this agent, and recent reports highlighted the presence of M1UK clones and a sublineage of M1 with the SpeC toxin in that country, which has been associated with this increase. In view of this situation, PAHO/WHO recommends that Member States conduct clinical and genomic surveillance, as well as ensure early diagnosis and timely treatment of cases of invasive group A streptococcal disease.

Upsurge of respiratory illnesses among children|23 November 2023|Northern China
At a press conference on 13 November 2023, China’s National Health Commission reported on a nationwide increase in the incidence of respiratory diseases, predominantly affecting children. Chinese authorities attributed this increase to lifting of COVID-19 restrictions and the arrival of the cold season, and due to circulating known pathogens such as influenza, Mycoplasma pneumoniae, respiratory syncytial virus (RSV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Mycoplasma pneumonia and RSV are known to affect children more than adults.

Mpox (monkeypox)|23 November 2023| Democratic Republic of the Congo
Cases with travel history to endemic provinces have been driving chains of human-to-human transmission in non-affected provinces (Figure 1 & 2).